BD 515078 - PhaSeal Adapter Infusion Closed System Drug Transfer Device, 40/BX
The BD 515078 PhaSeal Adapter Infusion is a closed system drug transfer device specifically designed to maintain a sealed pathway during the administration of hazardous medications. Manufactured byBecton, Dickinson and Company, this infusion adapter plays a critical role in reducing occupational exposure to hazardous drugs by preventing the escape of aerosols, vapors, and liquid contaminants during infusion.
Designed for use at the point of drug administration, the PhaSeal Infusion Adapter integrates seamlessly into IV infusion lines, supporting safe delivery of chemotherapy and other high-risk medications while maintaining workflow efficiency in clinical environments.
| Manufacturer | Application | For Use With |
| 515078 | Adapter | For Optima C100-O |
Key Benefits
The BD 515078 PhaSeal Infusion Adapter helps protect healthcare professionals by maintaining a closed system throughout the infusion process. Its design minimizes the risk of environmental contamination and accidental exposure during connection, disconnection, and administration.
The adapter supports consistent, leak-resistant connections and integrates smoothly into existing infusion setups. Its single-use construction supports infection control standards and eliminates the need for cleaning or reprocessing, helping facilities maintain consistent safety practices.
Compatibility and Applications
This infusion adapter is designed for compatibility with BD PhaSeal closed system components and standard IV infusion sets used in hazardous drug administration. It is commonly used in oncology units, infusion centers, hospital pharmacies, and outpatient treatment facilities.
Typical applications include chemotherapy administration, infusion of hazardous biologics, and other IV therapies where exposure control and regulatory compliance are essential.
Usage Guidelines
The BD 515078 PhaSeal Adapter Infusion should be used in accordance with institutional hazardous drug handling and infusion protocols. Prior to use, healthcare professionals should confirm compatibility with the intended IV line and PhaSeal system components.
Aseptic technique must be maintained throughout setup and administration. After completion of infusion, the adapter should be disposed of according to facility policy and hazardous waste handling guidelines. The device is intended for single use only.
Certifications, Safety Standards, and Regulatory Approvals
This product is manufactured under strict quality management systems aligned with FDA medical device regulations and internationally recognized manufacturing standards. These controls ensure consistent sealing performance, material integrity, and reliable function during hazardous drug infusion.
Regulatory compliance supports the products use in highly regulated healthcare environments and reinforces its role in occupational safety and exposure prevention programs.
Comparison with Competitor Products
Compared with standard infusion adapters or open IV connectors, the BD 515078 PhaSeal Infusion Adapter offers a significantly higher level of exposure protection by maintaining a closed system during administration. While some competitor products offer partial containment, BD PhaSeal devices are widely recognized for their robust sealing mechanisms and dependable performance.
Healthcare facilities often select BD PhaSeal systems due to their proven track record, consistent manufacturing quality, and alignment with evolving hazardous drug safety expectations.
Typical User Profile and Application Scenarios
Typical users include oncology nurses, infusion nurses, pharmacists, and other trained healthcare professionals responsible for administering hazardous IV medications.
The adapter is most effective in oncology clinics, infusion centers, hospital wards, and outpatient treatment settings where staff safety, patient care continuity, and regulatory compliance are critical priorities.
Best Practices for Use and Maintenance
Best practice includes comprehensive staff training on closed system infusion techniques and verification of correct component compatibility prior to use. The adapter should remain in its packaging until immediately before setup to preserve integrity.
After infusion is complete, the adapter should be disposed of promptly in accordance with hazardous waste protocols. As a single-use device, no maintenance or reprocessing is required.
Regulatory and Safety Information
The BD 515078 PhaSeal Adapter Infusion is classified as a regulated medical device and complies with applicable FDA requirements. Its use supports adherence to hazardous drug handling guidelines and occupational safety recommendations commonly enforced in healthcare settings.
Following manufacturer instructions and institutional policies ensures safe, compliant use while reducing the risk of occupational exposure.
How to Order
The BD 515078 PhaSeal Adapter Infusion is available for purchase through the CIA Medical website. Add the product to your cart and proceed through the secure checkout process.
For bulk orders, institutional pricing, or product-related assistance, contact CIA Medical customer service at 312 275 5850 or use the contact form available on this page for prompt support.
